KMTS
Kestra Medical Technologies, Ltd. Common Stock
NASDAQ: KMTS · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$19.51
-9.93% today
Updated 2026-04-29
Market cap
$1.14B
P/E ratio
—
P/S ratio
13.60x
EPS (TTM)
$-5.46
Dividend yield
—
52W range
$13 – $30
Volume
0.4M
Kestra Medical Technologies, Ltd. Common Stock (KMTS) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2020 | 2021 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $7.63M | $27.81M | $59.81M |
| Revenue growth (YoY) | — | — | — | +264.5% | +115.1% |
| Cost of revenue | — | — | $18.28M | $27.45M | $35.60M |
| Gross profit | — | — | $-10.65M | $362000.00 | $24.21M |
| Gross margin | — | — | -139.6% | 1.3% | 40.5% |
| R&D | $22.80M | $18.81M | $15.76M | $15.49M | $15.65M |
| SG&A | $6.52M | $13.90M | $19.09M | $29.25M | $114.94M |
| Operating income | $-29.32M | $-32.71M | $-80.42M | $-85.06M | $-106.38M |
| Operating margin | — | — | -1054.0% | -305.8% | -177.8% |
| EBITDA | $-28.84M | $-32.33M | $-73.74M | $-76.31M | $-97.98M |
| EBITDA margin | — | — | -966.4% | -274.3% | -163.8% |
| EBIT | $-29.32M | $-32.75M | $-78.59M | $-87.87M | $-105.94M |
| Interest expense | $0.00 | $1.17M | $5.63M | $6.23M | $7.73M |
| Income tax | $148000.00 | $187000.00 | $15000.00 | $24000.00 | $135000.00 |
| Effective tax rate | -0.5% | -0.6% | -0.0% | -0.0% | -0.1% |
| Net income | $-29.47M | $-34.10M | $-84.24M | $-94.12M | $-113.81M |
| Net income growth (YoY) | — | -15.7% | -147.0% | -11.7% | -20.9% |
| Profit margin | — | — | -1104.0% | -338.4% | -190.3% |